secwatch.observer — SEC 8-K summary
======================================

Issuer:     TG THERAPEUTICS, INC. (TGTX)
CIK:        0001001316
Form:       8-K
Filed at:   2026-06-12T20:32:23+00:00
Accession:  0001437749-26-020491
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TG Therapeutics say-on-pay fails at 2026 annual meeting; directors elected
--------------------------------------------------------------------------

- Proposal 3 (say-on-pay): 48.9M votes against vs 31.9M in favor; not approved.
- All six director nominees elected; Sagar Lonial received 54.85% support, lowest.
- Ratification of KPMG as auditor approved: 112.3M for, 531.8K against.
- Quorum of 113.0M shares (73.81% of outstanding) present at June 11 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/0001437749-26-020491-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001316/000143774926020491/tgtx20260612_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-020491

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer